The Health Pulse

Quick Lab Mobile

4.2 (5)
Medicine

🎙️ The Health Pulse – Your quick guide to better health! In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful. Listen, learn, and take control—one pulse at a time! 🔬✨

5d ago

Episode 139 | Insulin Resistance Under The Hood

Your fasting glucose and HbA1c can look normal while your pancreas is working overtime to keep them that way. In this episode of The Health Pulse, we explore intermittent fasting as a strategy for insulin resistance, starting with a metabolic problem that conventional glucose testing can easily overlook: normoglycemic hyperinsulinemia. Insulin resistance often develops long before blood glucose reaches the prediabetes range. As tissues become less responsive to insulin, pancreatic beta cells compensate by secreting more of it. Glucose may remain normal, but the metabolic cost of maintaining that normal glucose continues to rise. So where does fasting fit? We break down what happens when the time between meals increases. As insulin concentrations fall and liver glycogen is gradually depleted, the body becomes increasingly able to mobilize stored fatty acids and produce ketones. Rather than viewing fasting as a magic switch, we explain it as a way of creating longer periods of low insulin signaling and allowing the body to transition between stored and incoming fuels. We also examine the popular connection between fasting and autophagy. While fasting influences nutrient-sensing pathways involved in cellular recycling, there is no universal human “autophagy clock” that suddenly switches on at a specific fasting hour. More fasting isn't automatically better, and aggressive multi-day fasting can introduce nutritional, hormonal, and muscle-preservation concerns. For many people, a more sustainable strategy may be a consistent 12- to 14-hour overnight fasting window, particularly when paired with appropriate meal timing. We explore research on early time-restricted eating, where improvements in insulin sensitivity have been observed even without significant weight loss, highlighting the importance of circadian biology and the potential metabolic consequences of eating late into the evening. But fasting cannot compensate for everything. Adequate protein, resistance training, maintaining skeletal muscle, post-meal movement, sleep, and food quality remain fundamental. Skeletal muscle is a major destination for glucose disposal, making muscle preservation especially important when using fasting or calorie restriction to improve metabolic health. We also discuss who needs to be particularly careful with fasting. People using insulin, sulfonylureas, SGLT2 inhibitors, or other glucose-lowering medications may require medical guidance because fasting can change medication requirements and, depending on the drug, increase the risk of complications such as hypoglycemia or ketoacidosis. Finally, we explain how to look beyond glucose when tracking metabolic improvement, including fasting insulin, HOMA-IR, triglycerides, ApoB, waist circumference, and changes in body composition. Intermittent fasting isn't magic—and it isn't necessary for everyone. But when used appropriately, meal timing can become one tool for reducing constant insulin demand and creating a metabolic environment that supports better insulin sensitivity. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 31

Episode 138 | The Insulin Blind Spot

A normal fasting glucose or HbA1c doesn't necessarily mean your metabolism is healthy. For years, the pancreas may compensate for declining insulin sensitivity by producing increasingly larger amounts of insulin—keeping glucose looking reassuringly normal while metabolic dysfunction progresses beneath the surface. In this episode of The Health Pulse, we use Dr. Isabel Cooper's metabolic phenotype framework to explore the progression from normoglycemia with hyperinsulinemia to prediabetes and type 2 diabetes. Instead of looking only at glucose, we ask a more revealing question: how much insulin does your body need to produce to keep that glucose normal? We begin with the early compensatory phase, when insulin resistance develops but pancreatic beta cells can still increase insulin secretion enough to maintain normal blood glucose. This hyperinsulinemic, normoglycemic state can precede conventional diagnostic abnormalities and may provide an earlier opportunity to recognize metabolic dysfunction. From there, we follow the progression into impaired glucose regulation and established type 2 diabetes, eventually examining what happens when beta cells can no longer maintain the enormous insulin demand placed upon them. We also explore C-peptide as a marker of endogenous insulin production and why advanced beta-cell failure can create a very different metabolic picture from early hyperinsulinemic disease. The episode also examines selective hepatic insulin resistance, explaining how the liver can continue producing glucose while insulin-driven pathways contributing to fat production remain active. This helps connect insulin resistance with elevated triglycerides, ectopic liver fat, MASLD, glucotoxicity, lipotoxicity, and increasing cardiovascular risk. We then tackle an important distinction in diabetes management: improving HbA1c versus improving the underlying metabolic physiology. Clinical remission is valuable, but we explore why lower insulin demand, improved insulin sensitivity, reduced ectopic fat, and greater metabolic flexibility provide additional context when evaluating metabolic recovery. Finally, we focus on earlier detection and prevention. We discuss fasting insulin alongside fasting glucose, HOMA-IR, insulin measurements during an oral glucose tolerance test, ApoB, and C-peptide, as well as the influence of skeletal muscle, resistance training, sleep, cortisol, and the personal fat threshold on insulin sensitivity. If you've ever been told that your glucose is normal and assumed that means insulin resistance isn't developing, this episode explains why glucose may be only one part of the metabolic story. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 27

Episode 137 | GKI and Cancer: Can Metabolic Therapy Really Starve a Tumor?

Stop eating sugar and you'll starve cancer” sounds convincing—but cancer metabolism is far more complicated. In this episode of The Health Pulse, we examine the science behind ketogenic metabolic therapy, the Glucose Ketone Index (GKI), and cancer, separating a legitimate area of research from claims that run far ahead of the evidence. We begin with the Warburg effect, the observation that many cancer cells consume large amounts of glucose and rely heavily on glycolysis even when oxygen is available. What appears inefficient from an energy perspective can provide rapidly dividing cells with metabolic intermediates needed to build proteins, lipids, nucleotides, and ultimately new tumor cells. This unusually high glucose uptake is so characteristic of many cancers that modern FDG-PET imaging exploits it to help identify metabolically active tissue. But that doesn't mean removing dietary sugar simply removes glucose from the body. The liver can manufacture glucose through gluconeogenesis, tightly defending blood glucose for tissues that require it. Instead, researchers studying ketogenic metabolic therapy are asking a more nuanced question: can lowering circulating glucose and insulin while increasing ketone bodies such as beta-hydroxybutyrate (BHB) create a metabolic environment that disadvantages certain tumors while continuing to fuel healthy tissue? That brings us to the Glucose Ketone Index. GKI combines blood glucose and ketone concentrations into a single ratio designed to describe the balance between these two circulating fuels. We explain how it's calculated, why researchers use it in metabolic oncology, and why chasing an extremely low GKI without clinical supervision can be dangerous. We also examine the current evidence, including recent research on ketogenic metabolic strategies in aggressive brain tumors. While findings remain scientifically interesting, GKI is not an established cancer-treatment target, and ketogenic therapy has not been proven to replace surgery, chemotherapy, radiation, immunotherapy, or other standard oncology treatments. Safety becomes especially important because cancer changes the metabolic equation. Cachexia, unintended weight loss, inadequate protein and calorie intake, medication interactions, and treatment-related nutritional problems can make aggressive fasting or carbohydrate restriction harmful for some patients. Glucose and ketone readings are also affected by stress hormones, sleep, medications, meal timing, and the dawn phenomenon, making isolated measurements easy to misinterpret. The takeaway isn't that metabolism doesn't matter—it clearly does. It's that metabolic therapy must be studied and applied with the same scientific rigor as any other cancer intervention. If you're interested in cancer metabolism, ketogenic therapy, GKI, or evidence-based oncology nutrition, this episode provides a framework for understanding what's promising, what's uncertain, and why careful medical supervision matters. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 26

Episode 136 | FIB-4 and Metabolic Liver Disease

Your AST and ALT can be completely normal while liver fibrosis is quietly developing. In this episode of The Health Pulse, we explore one of the biggest blind spots in routine liver testing and explain why FIB-4 can provide important information that a standard liver panel may miss. We begin with metabolic dysfunction-associated steatotic liver disease (MASLD), the condition formerly known as NAFLD. Closely connected to insulin resistance, visceral fat, prediabetes, and type 2 diabetes, MASLD can progress silently from excess liver fat to inflammation and eventually fibrosis—the accumulation of scar tissue that ultimately determines much of the long-term risk of cirrhosis and liver-related complications. We break down the metabolic biology behind that progression, including de novo lipogenesis, where excess energy—particularly from carbohydrates and fructose—can be converted into fat inside the liver. As metabolic dysfunction progresses, lipotoxicity, oxidative stress, and inflammation can push simple steatosis toward MASH and eventually fibrosis. Then we address the problem with relying on liver enzymes alone. AST and ALT primarily reflect cellular injury; they do not directly measure fibrosis. Someone can therefore have clinically important liver disease without dramatically elevated enzymes, making a row of green check marks on a laboratory portal potentially misleading. That's where the FIB-4 index becomes useful. Using only age, AST, ALT, and platelet count, FIB-4 provides a noninvasive first-line estimate of the likelihood of advanced liver fibrosis. We explain the commonly used low-, intermediate-, and high-risk thresholds, why age changes interpretation, and how platelet counts and the relationship between AST and ALT can provide clues about advancing disease. An abnormal FIB-4 isn't a diagnosis. Instead, it can identify people who may benefit from further evaluation with tools such as transient elastography (FibroScan) or the Enhanced Liver Fibrosis (ELF) test. Finally, we discuss what can change the trajectory. Weight reduction when appropriate, resistance and aerobic exercise, improved insulin sensitivity, and nutritional strategies can substantially reduce liver fat and metabolic stress. We also look at the evolving treatment landscape, including medications such as resmetirom and semaglutide for appropriately selected patients with MASH and fibrosis. And because MASLD rarely exists in isolation, we connect liver health back to cardiovascular risk through ApoB and the broader metabolic picture. If your annual physical says your liver enzymes are "normal," this episode explains why that shouldn't always be the end of the conversation—and how information already sitting inside routine bloodwork may help identify fibrosis risk earlier. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 25

Episode 135 | The Heart Risk Your Cholesterol Test Misses

A “perfect” cholesterol test can still hide a dangerous cardiovascular trajectory. The 2026 ACC/AHA multisociety dyslipidemia guideline reflects a more complete way of evaluating risk—one that looks beyond LDL cholesterol alone. In this episode of The Health Pulse, we explain why LDL-C measures the cholesterol carried inside lipoproteins but does not directly reveal how many atherogenic particles are circulating. Those particles can enter the artery wall, become trapped and modified, trigger inflammation, and contribute to plaque formation. We break down ApoB as a practical measurement of atherogenic particle number and use a simple highway analogy to explain cholesterol discordance. This distinction is especially important for people with insulin resistance, metabolic syndrome, elevated triglycerides, fatty liver, or type 2 diabetes, whose LDL-C may appear reassuring even while ApoB remains elevated. We also examine lipoprotein(a), or Lp(a), a largely inherited cardiovascular risk factor that may remain high despite a healthy lifestyle. You will learn why adults should generally have Lp(a) measured at least once, how an elevated result can influence risk assessment, and why it may justify testing close family members. The conversation also covers the updated PREVENT cardiovascular risk equations, the return of clearer LDL-C treatment goals, when coronary artery calcium scanning can help resolve uncertainty, and how treatment may progress from lifestyle changes to statins, ezetimibe, PCSK9-targeting therapies, and other individualized options. If you have ever been told your cholesterol is “normal,” this episode will help you understand what a basic lipid panel may still be missing—and which tests can provide a more complete picture of cardiovascular risk. Subscribe to The Health Pulse for evidence-based conversations about metabolic health, laboratory testing, and disease prevention. Share this episode with someone who believes normal cholesterol automatically means low cardiovascular risk. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 18

Episode 134 | Mitochondrial Biogenesis

Your mitochondria aren't static batteries that simply wear out with age. They're part of a dynamic network that is constantly being broken down, repaired, recycled, and rebuilt according to the demands you place on your body. In this episode of The Health Pulse, we explore mitochondrial biogenesis—the process cells use to expand and upgrade their capacity to produce energy. We begin with one of biology's most fascinating coordination problems. Mitochondria contain their own DNA, yet the vast majority of the proteins they need are encoded by DNA inside the nucleus. Building new mitochondrial capacity therefore requires constant communication between these two genetic systems. We explain how PGC-1α acts like a molecular general contractor, coordinating nuclear gene expression and helping activate proteins such as TFAM, which must then be transported back into mitochondria to support mitochondrial DNA replication and function. From there, we connect the molecular biology to something familiar: exercise and recovery. Training temporarily creates metabolic stress rather than instantly making you stronger. That stress activates signaling pathways telling the cell that its existing energy infrastructure isn't sufficient. During recovery, the body adapts by improving mitochondrial capacity—a classic example of hormesis, where an appropriate dose of stress stimulates greater resilience. We compare how Zone 2 aerobic exercise, high-intensity interval training (HIIT), and resistance training challenge mitochondrial biology in different ways. We also examine the opposite scenario: what happens when physical demand disappears while energy intake remains high. Excess fuel can accumulate where it doesn't belong, contributing to ectopic fat, ceramide formation, impaired insulin signaling, and declining metabolic flexibility. The episode also takes a critical look at popular mitochondrial "biohacks," including fasting, ketogenic diets, cold exposure, NAD-related supplements, and resveratrol. While some influence pathways associated with mitochondrial function, changing a molecular pathway or biomarker doesn't automatically translate into meaningful improvements in human health. We also discuss why excessive doses of isolated antioxidants may sometimes interfere with the oxidative signals that help drive exercise adaptation. Finally, we explain what you can actually measure. There is no routine blood test for mitochondrial biogenesis itself, but laboratory markers can reveal metabolic or nutritional roadblocks that interfere with energy production and adaptation. These include fasting insulin, HbA1c, triglycerides, ApoB, CBC, ferritin and iron studies, TSH, free T4, and hs-CRP. If you're trying to improve energy, metabolic health, exercise performance, or healthy aging, this episode offers a different framework: don't just ask how to get more energy today—ask what signals you're giving your cells to build greater energy capacity tomorrow. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 13

Episode 133 | Mitophagy And Real Energy

What if improving cellular energy isn't just about making more mitochondria—but getting rid of the damaged ones first? In this episode of The Health Pulse, we explore mitophagy, the highly selective quality-control process cells use to identify, dismantle, and recycle dysfunctional mitochondria. We begin with the mitochondrial power-grid model. A cell packed with damaged mitochondria isn't necessarily better equipped to produce energy. Dysfunctional mitochondria can generate less ATP while producing excessive reactive oxygen species and inflammatory signals. Sometimes, fewer but healthier mitochondria create a more resilient cellular energy system. We break down the fascinating molecular machinery behind this cleanup process. When a mitochondrion loses its membrane potential, PINK1 accumulates on its outer membrane, helping recruit Parkin, which tags damaged mitochondrial proteins with ubiquitin. Combined with mitochondrial fission and fusion, this system helps isolate dysfunctional components before an autophagosome surrounds them and ultimately delivers them to lysosomes for degradation and recycling. When this quality-control system fails, the consequences can extend far beyond energy production. Mutations affecting the PINK1-Parkin pathway are associated with forms of early-onset Parkinson's disease, while severely damaged mitochondria can release mitochondrial DNA and other danger signals capable of activating inflammatory pathways such as cGAS-STING and the NLRP3 inflammasome. So how do we support mitochondrial quality control? We examine why exercise remains one of the strongest evidence-based interventions, activating energy-sensing pathways involving AMPK and ULK1 while stimulating mitochondrial remodeling. We also explore mitohormesis, where temporary metabolic stress produces adaptations that make cells more resilient, and the role of PGC-1α in coordinating mitochondrial biogenesis after damaged components have been cleared. We also challenge popular claims about fasting and supplements. There isn't a universal fasting hour when autophagy suddenly "switches on," and chronic energy restriction can eventually become counterproductive. Emerging compounds such as urolithin A are scientifically interesting, but we explain why autophagic flux matters: activating the beginning of a recycling pathway doesn't necessarily prove that the entire cleanup process is functioning effectively. Finally, we discuss how mitochondrial health can be evaluated in the real world. There is no routine blood test that produces a simple "mitophagy score," but markers such as fasting insulin, HbA1c, triglycerides, ApoB, thyroid function, iron status, and vitamin B12 can help reveal the metabolic and nutritional environment in which mitochondrial repair must operate. If you're interested in longevity, metabolic health, cellular energy, or why you constantly feel exhausted, this episode reveals one of the body's most sophisticated maintenance systems—and why mitochondrial health depends on both building and recycling. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Aug 12

Episode 132 | Humanin

Mitochondria are famous for producing energy, but that description barely scratches the surface. These organelles also communicate with the rest of the cell, responding to stress and influencing decisions about repair, adaptation, inflammation, and even programmed cell death. In this episode of The Health Pulse, we explore one of the most fascinating messengers involved in that conversation: humanin. Humanin is a small mitochondrial-derived peptide first identified during research into cellular protection against Alzheimer’s-related toxicity. Its discovery helped expand an emerging view of mitochondria—not simply as cellular power plants, but as signaling centers capable of communicating their metabolic condition back to the nucleus through mitochondrial retrograde signaling. We break down one of humanin's most intriguing areas of research: apoptosis, the carefully controlled process cells use to eliminate themselves when damage becomes severe. You'll learn how mitochondrial cytochrome c release can initiate apoptosome formation and activate caspases, and how humanin has been studied for its ability to interact with proteins such as Bax while influencing survival pathways including JAK-STAT3 and PI3K-AKT. But keeping cells alive isn't automatically beneficial. We examine the important questions surrounding excessive anti-apoptotic signaling, including why mechanisms that protect vulnerable neurons in one setting could theoretically become problematic when abnormal or damaged cells should be eliminated. This is especially relevant when considering aging, cancer biology, and the growing market for experimental peptides. From there, we connect humanin to the broader biology of reactive oxygen species, oxidative stress, and mitohormesis, examining why tissues with enormous energy demands can be particularly vulnerable to mitochondrial dysfunction. That includes the brain, the vascular endothelium responsible for nitric oxide signaling, and pancreatic beta cells that depend on mitochondrial ATP production to properly coordinate insulin secretion. Finally, we separate measurable biology from peptide-industry hype. Humanin isn't currently a routine clinical biomarker, so we discuss more practical laboratory markers—including fasting insulin, HbA1c, ApoB, hs-CRP, and comprehensive metabolic testing—that can provide insight into the metabolic environment surrounding mitochondrial health. If you're interested in mitochondrial biology, longevity, metabolic health, or emerging peptide science, this episode reveals just how much more mitochondria do than make energy—and why understanding their signals may reshape how we think about aging and disease. 📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required. 📅 Book your appointment or learn more at: 👉 Quick Lab Mobile 📧 Contact us: info@quicklabmobile.com 💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most. Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.

4.2

out of 5

5 Ratings

🎙️ The Health Pulse – Your quick guide to better health! In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful. Listen, learn, and take control—one pulse at a time! 🔬✨

Creator

Quick Lab Mobile
Years Active

2025 - 2026
Episodes

139
Rating

Clean
Copyright

© 2026 Quick Lab Mobile
Show Website

The Health Pulse